Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Ribavirin; Sofosbuvir
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Dec 2016 Planned number of patients changed from 20 to 10.
- 15 Dec 2016 Planned number of patients changed from 10 to 20.
- 17 May 2016 Status changed from not yet recruiting to recruiting.